-
公开(公告)号:US09669105B2
公开(公告)日:2017-06-06
申请号:US13881976
申请日:2011-10-26
申请人: Dae Seong Im , Jae Min Lee , Jong Soo Lee , Sung Min Bae , Se Chang Kwon
发明人: Dae Seong Im , Jae Min Lee , Jong Soo Lee , Sung Min Bae , Se Chang Kwon
CPC分类号: A61K47/48415 , A61K9/0019 , A61K38/212 , A61K47/26 , A61K47/68 , A61K47/6813 , C07K14/56 , C07K16/46 , C07K2319/30
摘要: Disclosed is a liquid formulation in which a long-acting INFα conjugate that has improved in vivo duration and stability can be stored stably for a long period of time. It comprises a stabilizer comprising a buffer, a sugar alcohol, a non-ionic surfactant and an isotonic agent. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting INFα conjugates.
-
公开(公告)号:US20130287734A1
公开(公告)日:2013-10-31
申请号:US13881976
申请日:2011-10-26
申请人: Dae Seong Im , Jae Min Lee , Jong Soo Lee , Sung Min Bae , Se Chang Kwon
发明人: Dae Seong Im , Jae Min Lee , Jong Soo Lee , Sung Min Bae , Se Chang Kwon
CPC分类号: A61K47/48415 , A61K9/0019 , A61K38/212 , A61K47/26 , A61K47/68 , A61K47/6813 , C07K14/56 , C07K16/46 , C07K2319/30
摘要: Disclosed is a liquid formulation in which a long-acting INFα conjugate that has improved in vivo duration and stability can be stored stably for a long period of time. It comprises a stabilizer comprising a buffer, a sugar alcohol, a non-ionic surfactant and an isotonic agent. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting INFα conjugates.
摘要翻译: 公开了一种液体制剂,其中可长期稳定地储存具有改善的体内持续时间和稳定性的长效INFalpha缀合物。 它包括稳定剂,其包含缓冲剂,糖醇,非离子表面活性剂和等渗剂。 没有人体血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证对长效INFalpha缀合物的优良储存稳定性。
-
公开(公告)号:US09061072B2
公开(公告)日:2015-06-23
申请号:US13809783
申请日:2011-07-14
申请人: Sung Hee Hong , Byung Sun Lee , Dae Seong Im , Jae Min Lee , Sung Min Bae , Se Chang Kwon
发明人: Sung Hee Hong , Byung Sun Lee , Dae Seong Im , Jae Min Lee , Sung Min Bae , Se Chang Kwon
CPC分类号: A61K47/48415 , A61K9/0019 , A61K9/08 , A61K38/27 , A61K47/12 , A61K47/26 , A61K47/60 , A61K47/68 , C07K2319/30
摘要: Disclosed is a liquid formulation of long-acting human growth hormone (hGH) conjugate, free of albumin, which can guarantee the stability of the long-acting hGH conjugate when stored over a long period of time, wherein the long-acting human growth hormone conjugate includes a human growth hormone linked to an immunoglobulin Fc region, and has a prolonged in vivo stability compared to the native form. The liquid formulation of hGH conjugate including a pH 5.0˜6.0 buffer, a sugar alcohol, a salt and a non-ionic surfactant is free of human serum albumin and other hazardous factors which are potentially contaminated with viruses, and can provide excellent storage stability customized for a long-acting hGH conjugate composed of an hGH polypeptide and an immunoglobulin Fc region which has higher molecular weight and in vivo durability, compared to the native.
摘要翻译: 公开了长效人生长激素(hGH)缀合物的液体制剂,其不含白蛋白,其可以长期保存长效hGH缀合物的稳定性,其中长效人生长激素 缀合物包括与免疫球蛋白Fc区连接的人生长激素,并且与天然形式相比具有延长的体内稳定性。 包含pH 5.0〜6.0缓冲液,糖醇,盐和非离子表面活性剂的hGH缀合物的液体制剂不含人血清白蛋白和潜在的病毒污染的其他有害因素,可提供优良的储存稳定性 对于由hGH多肽和具有较高分子量和体内耐久性的免疫球蛋白Fc区组成的长效hGH缀合物,与天然产物相比。
-
公开(公告)号:US20130115231A1
公开(公告)日:2013-05-09
申请号:US13809783
申请日:2011-07-14
申请人: Sung Hee Hong , Byung Sun Lee , Dae Seong Im , Jae Min Lee , Sung Min Bae , Se Chang Kwon
发明人: Sung Hee Hong , Byung Sun Lee , Dae Seong Im , Jae Min Lee , Sung Min Bae , Se Chang Kwon
IPC分类号: A61K47/48
CPC分类号: A61K47/48415 , A61K9/0019 , A61K9/08 , A61K38/27 , A61K47/12 , A61K47/26 , A61K47/60 , A61K47/68 , C07K2319/30
摘要: Disclosed is a liquid formulation of long-acting human growth hormone (hGH) conjugate, free of albumin, which can guarantee the stability of the long-acting hGH conjugate when stored over a long period of time, wherein the long-acting human growth hormone conjugate includes a human growth hormone linked to an immunoglobulin Fc region, and has a prolonged in vivo stability compared to the native form. The liquid formulation of hGH conjugate including a pH 5.0˜6.0 buffer, a sugar alcohol, a salt and a non-ionic surfactant is free of human serum albumin and other hazardous factors which are potentially contaminated with viruses, and can provide excellent storage stability customized for a long-acting hGH conjugate composed of an hGH polypeptide and an immunoglobulin Fc region which has higher molecular weight and in vivo durability, compared to the native.
摘要翻译: 公开了长效人生长激素(hGH)缀合物的液体制剂,其不含白蛋白,其可以长期保存长效hGH缀合物的稳定性,其中长效人生长激素 缀合物包括与免疫球蛋白Fc区连接的人生长激素,并且与天然形式相比具有延长的体内稳定性。 包含pH 5.0〜6.0缓冲液,糖醇,盐和非离子表面活性剂的hGH缀合物的液体制剂不含人血清白蛋白和其他可能被病毒污染的危险因素,可以提供优良的储存稳定性 对于由hGH多肽和具有较高分子量和体内耐久性的免疫球蛋白Fc区组成的长效hGH缀合物,与天然产物相比。
-
公开(公告)号:US09492507B2
公开(公告)日:2016-11-15
申请号:US13638786
申请日:2011-04-04
申请人: Dae Hae Song , Jae Hee Shin , Young Jin Park , Dae Seong Im , Sung Min Bae , Se Chang Kwon
发明人: Dae Hae Song , Jae Hee Shin , Young Jin Park , Dae Seong Im , Sung Min Bae , Se Chang Kwon
CPC分类号: A61K38/28 , A61K47/68 , A61K47/6883 , C07K14/62 , C07K2319/30
摘要: The present invention relates to an insulin conjugate having improved in vivo duration and stability, which is prepared by covalently linking insulin with an immunoglobulin Fc region via a non-peptidyl polymer, a long-acting formulation comprising the same, and a preparation method thereof. The insulin conjugate of the present invention maintains in vivo activity of the peptide at a relatively high level and remarkably increases the serum half-life thereof, thereby greatly improving drug compliance upon insulin treatment.
摘要翻译: 本发明涉及具有改善的体内持续时间和稳定性的胰岛素缀合物,其通过非肽基聚合物共价连接胰岛素与免疫球蛋白Fc区,包含其的长效制剂及其制备方法制备。 本发明的胰岛素结合物以较高水平保持肽的体内活性,并显着增加血清的半衰期,从而大大提高了胰岛素治疗后的药物依从性。
-
公开(公告)号:US08829163B2
公开(公告)日:2014-09-09
申请号:US13574029
申请日:2011-01-18
申请人: Sung Min Bae , Dae Seong Im , Min Young Kim , Chang Ki Lim , Sung Youb Jung , Se Chang Kwon
发明人: Sung Min Bae , Dae Seong Im , Min Young Kim , Chang Ki Lim , Sung Youb Jung , Se Chang Kwon
IPC分类号: A61K39/00 , C07K16/00 , A61K47/02 , A61K47/26 , A61K47/48 , A61K47/18 , A61K9/00 , A61K47/10
CPC分类号: A61K47/02 , A61K9/0019 , A61K38/00 , A61K47/10 , A61K47/183 , A61K47/26 , A61K47/6811 , A61K47/6835
摘要: Disclosed is a liquid formulation which allows long-acting EPO conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting EPO conjugates.
摘要翻译: 公开了一种液体制剂,其允许具有改善的体内持续时间和稳定性的长效EPO缀合物在长时间储存时是稳定的。 它包括以缓冲液和甘露醇为特征的稳定剂组合物。 没有人血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证了对长效EPO共轭物的极好的储存稳定性。
-
公开(公告)号:US20130028918A1
公开(公告)日:2013-01-31
申请号:US13638786
申请日:2011-04-04
申请人: Dae Hae Song , Jae Hee Shin , Young Jin Park , Dae Seong Im , Sung Min Bae , Se Chang Kwon
发明人: Dae Hae Song , Jae Hee Shin , Young Jin Park , Dae Seong Im , Sung Min Bae , Se Chang Kwon
IPC分类号: A61K39/395 , A61P3/10 , C07K16/00
CPC分类号: A61K38/28 , A61K47/68 , A61K47/6883 , C07K14/62 , C07K2319/30
摘要: The present invention relates to an insulin conjugate having improved in vivo duration and stability, which is prepared by covalently linking insulin with an immunoglobulin Fc region via a non-peptidyl polymer, a long-acting formulation comprising the same, and a preparation method thereof. The insulin conjugate of the present invention maintains in vivo activity of the peptide at a relatively high level and remarkably increases the serum half-life thereof, thereby greatly improving drug compliance upon insulin treatment.
摘要翻译: 本发明涉及具有改善的体内持续时间和稳定性的胰岛素缀合物,其通过非肽基聚合物共价连接胰岛素与免疫球蛋白Fc区,包含其的长效制剂及其制备方法制备。 本发明的胰岛素结合物以较高水平保持肽的体内活性,并显着增加血清的半衰期,从而大大提高了胰岛素治疗后的药物依从性。
-
公开(公告)号:US20120296069A1
公开(公告)日:2012-11-22
申请号:US13574029
申请日:2011-01-18
申请人: Sung Min Bae , Dae Seong Im , Min Young Kim , Chang Ki Lim , Sung Youb Jung , Se Chang Kwon
发明人: Sung Min Bae , Dae Seong Im , Min Young Kim , Chang Ki Lim , Sung Youb Jung , Se Chang Kwon
IPC分类号: C07K16/00
CPC分类号: A61K47/02 , A61K9/0019 , A61K38/00 , A61K47/10 , A61K47/183 , A61K47/26 , A61K47/6811 , A61K47/6835
摘要: Disclosed is a liquid formulation which allows long-acting EPO conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting EPO conjugates.
摘要翻译: 公开了一种液体制剂,其允许具有改善的体内持续时间和稳定性的长效EPO缀合物在长时间储存时是稳定的。 它包括以缓冲液和甘露醇为特征的稳定剂组合物。 没有人血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证了对长效EPO共轭物的极好的储存稳定性。
-
公开(公告)号:US20120294829A1
公开(公告)日:2012-11-22
申请号:US13574039
申请日:2011-01-18
申请人: Mi Ji Lee , Jae Min Lee , Byung Sun Lee , Sung Min Bae , Se Chang Kwon
发明人: Mi Ji Lee , Jae Min Lee , Byung Sun Lee , Sung Min Bae , Se Chang Kwon
IPC分类号: A61K38/19
CPC分类号: A61K9/0019 , A61K38/193 , A61K47/12 , A61K47/26 , A61K47/6813 , A61K47/6835 , C07K14/535
摘要: Disclosed is a liquid formulation which allows long-acting G-CSF conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting G-CSF conjugates.
摘要翻译: 本发明公开了一种允许长效G-CSF缀合物的液体制剂,其具有改善的体内持续时间和稳定性,在长时间储存时是稳定的。 它包括以缓冲液和甘露醇为特征的稳定剂组合物。 没有人体血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证了对长效G-CSF缀合物的极好的储存稳定性。
-
公开(公告)号:US09867777B2
公开(公告)日:2018-01-16
申请号:US13574039
申请日:2011-01-18
申请人: Mi Ji Lee , Jae Min Lee , Byung Sun Lee , Sung Min Bae , Se Chang Kwon
发明人: Mi Ji Lee , Jae Min Lee , Byung Sun Lee , Sung Min Bae , Se Chang Kwon
CPC分类号: A61K9/0019 , A61K38/193 , A61K47/12 , A61K47/26 , A61K47/6813 , A61K47/6835 , C07K14/535
摘要: Disclosed is a liquid formulation which allows long-acting G-CSF conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting G-CSF conjugates.
-
-
-
-
-
-
-
-
-